Business
Divi’s Laboratories Q4 Result FY26: API Recovery Drives a Strong Earnings Comeback
The long wait for pharmaceutical investors is finally over as Divi’s Laboratories Limited announced its Q4 FY26 results on May…
Business
Fortis Healthcare Q4 Result FY26: Net Profit Surges 44% as India’s Healthcare Boom Gains Momentum
Fortis Healthcare Limited delivered one of the strongest quarterly performances in India’s healthcare sector after announcing its Q4 FY26 results…
Business
Sun Pharma Q4 Result FY26: Profit Jumps 26% as Innovative Medicines Shield US Headwinds—Is it a Buy?
India’s largest pharmaceutical company, Sun Pharmaceutical Industries Limited, announced its Q4 FY26 earnings on May 22, 2026, and the results…
Business
Aurobindo Pharma Q4 Result FY26: Profit Rises to ₹921 Crore as Europe Crosses Historic €1 Billion Revenue Milestone
Aurobindo Pharma Limited announced its Q4 FY26 financial results on May 21, 2026, and the earnings report immediately attracted strong…
Business
Max Healthcare Q4 Result FY26: Profit Rises 7% to ₹342 Crore Despite Margin Pressure, ₹2 Dividend Declared
Max Healthcare Institute Limited announced its Q4 FY26 financial results on May 21, 2026, and once again demonstrated why India’s…
Business
Eris Lifesciences Q4 Result FY26: Profit Triples to ₹281 Crore, But There’s a Major Catch Investors Should Understand
Eris Lifesciences Limited delivered one of the most discussed pharmaceutical earnings reports of Q4 FY26 after announcing its latest quarterly…
Business
Apollo Hospitals Q4 Results FY26: Net Profit Skyrockets 36% to ₹529 Crore; Is the All-Time High Stock Breakout a Buy?
If you’ve been holding shares of Apollo Hospitals Enterprise Limited, your portfolio likely witnessed one of its strongest sessions of…
Business
Mankind Pharma Q4 Result FY26: Profit Jumps 30% as Chronic Portfolio Fires on All Cylinders
India’s pharmaceutical sector witnessed another strong earnings surprise as Mankind Pharma Limited delivered an impressive Q4 FY26 performance that reinforced…
Business
Zydus Lifesciences Q4 Result FY26: Stellar Earnings Beat, ₹1,100 Crore Buyback Sparks Pharma Rally
Pharmaceutical giant Zydus Lifesciences sent shockwaves through Dalal Street today, turning what was expected to be a routine Q4 FY26…
Business
Gland Pharma Q4 Result FY26: Profit Doubles, Margins Expand and the Turnaround Story Gets Stronger
Introduction: Gland Pharma’s Blowout Quarter Changes Market Sentiment Injectables major Gland Pharma delivered one of the strongest pharmaceutical earnings surprises…